IT’S only halfway through 2021, but biotech startups in Singapore have attracted a record amount of capital from venture funds, giving the oft-sidelined sector a fillip amid some tailwinds from the pandemic.
Read More
IT’S only halfway through 2021, but biotech startups in Singapore have attracted a record amount of capital from venture funds, giving the oft-sidelined sector a fillip amid some tailwinds from the pandemic.
Read More
